[HTML][HTML] Bleeding avoidance strategies in percutaneous coronary intervention
For many years, bleeding has been perceived as an unavoidable consequence of strategies
aimed at reducing thrombotic complications in patients undergoing percutaneous coronary …
aimed at reducing thrombotic complications in patients undergoing percutaneous coronary …
Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective …
A growing number of patients undergoing percutaneous coronary intervention (PCI) with
stent implantation also have atrial fibrillation. This poses challenges for their optimal …
stent implantation also have atrial fibrillation. This poses challenges for their optimal …
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR
Aims Patients at high bleeding risk (HBR) represent a prevalent subgroup among those
undergoing percutaneous coronary intervention (PCI). Early aspirin discontinuation after a …
undergoing percutaneous coronary intervention (PCI). Early aspirin discontinuation after a …
Assessing the risks of bleeding vs thrombotic events in patients at high bleeding risk after coronary stent implantation: the ARC–high bleeding risk trade-off model
P Urban, J Gregson, R Owen, R Mehran… - JAMA …, 2021 - jamanetwork.com
Importance Patients who are candidates for percutaneous coronary intervention (PCI) and
are at high bleeding risk constitute a therapeutic challenge because they often also face an …
are at high bleeding risk constitute a therapeutic challenge because they often also face an …
Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI
Background The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention (PCI) among patients at high bleeding risk (HBR) is unknown …
coronary intervention (PCI) among patients at high bleeding risk (HBR) is unknown …
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside
J Nicolas, CA Pivato, M Chiarito… - Cardiovascular …, 2023 - academic.oup.com
Coronary stents have revolutionized the treatment of coronary artery disease. Compared
with balloon angioplasty, bare-metal stents (BMSs) effectively prevented abrupt vessel …
with balloon angioplasty, bare-metal stents (BMSs) effectively prevented abrupt vessel …
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
F Andreotti, T Geisler, JP Collet, B Gigante… - European Heart …, 2023 - academic.oup.com
The first international guidance on antithrombotic therapy in the elderly came from the
European Society of Cardiology Working Group on Thrombosis in 2015. This same group …
European Society of Cardiology Working Group on Thrombosis in 2015. This same group …
[HTML][HTML] High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry: High bleeding risk …
M Nakamura, K Kadota, K Nakao, Y Nakagawa… - …, 2021 - ncbi.nlm.nih.gov
Aims We aimed to evaluate the validity of the Academic Research Consortium for High
Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary …
Bleeding Risk (ARC-HBR) criteria for East Asian patients undergoing contemporary …
Abbreviated or standard dual antiplatelet therapy by sex in patients at high bleeding risk: a prespecified secondary analysis of a randomized clinical trial
Importance Abbreviated dual antiplatelet therapy (DAPT) reduces bleeding with no increase
in ischemic events in patients at high bleeding risk (HBR) undergoing percutaneous …
in ischemic events in patients at high bleeding risk (HBR) undergoing percutaneous …
Management of acute coronary syndromes in older adults
Older patients are underrepresented in prospective studies and randomized clinical trials of
acute coronary syndromes (ACS). Over the last decade, a few specific trials have been …
acute coronary syndromes (ACS). Over the last decade, a few specific trials have been …